Aims To investigate the involvement of enterovirus infection in chronic, rheumatic heart disease.
Introduction
Rheumatic fever remains the single most important cause of valvular heart disease worldwide and chronic rheumatic heart disease is the major cause of cardiovascular death during the first five decades of life [1, 2] . There has been a resurgence in both Europe and U.S.A. [3] [4] [5] after three decades in which the disease was thought to have been almost eradicated from developed countries. It is estimated by the World Health Organization that there are 1·5 million children with chronic rheumatic heart disease in industrialized countries, but 30 million in developing countries [6, 7] . Rheumatic heart disease has been viewed as an autoimmune condition triggered by throat infection with Group A streptococci, although one-third of sufferers give no history of sore throat and are culture negative for streptococci. Pharyngitis caused by streptococcal infection remains common in populations where rheumatic fever has become rare but only 3% of individuals with this condition develop rheumatic heart disease, even when there is a systemic antibody response and antibiotics are not given [8] . Streptococcal antibodies cross-reactive with human cardiac myocytes or with cartilage have been detected in patients with streptococcal pharyngitis uncomplicated by rheumatic heart disease and a high proportion of patients with chronic rheumatic heart disease have no history of rheumatism [9] . In addition, rheumatic fever does not follow repeated streptococcal infections of the skin and the course of acute rheumatic heart disease does not always coincide with a rise of streptococcal antibodies [10] . Experimental inoculation of animals with streptococci or streptococcal antigens does not produce myocardial or valvular lesions characteristic of acute or chronic rheumatic heart disease [11] and attempts to demonstrate streptococcal antigens in valvular tissue in rheumatic heart disease were negative [12] . It is believed that additional or more important factors in rheumatic fever or chronic rheumatic heart disease have not yet been recognized.
Enteroviruses are common agents of upper respiratory tract infection e.g. pharyngitis and cardiovascular disease including valvulitis in humans or experimental animals [13, 14] . The virus genome consists of a positive sense, single-stranded RNA of about 7400 nucleotides which encodes a single large precursor polyprotein, cleaved subsequently by viral proteases to yield individual structural (VP1 to VP4) and non-structural proteins. On infection, positive sense virus genomic RNA serves as a template for transcription of the complementary negative strand by the virus coded RNA polymerase 3D pol , producing an intermediate double-stranded replication. The negative strand then serves preferentially as a template for asymmetrical synthesis by 3D pol of multiple copies of positive sense RNA: these function as monocistronic mRNA or are packaged as genomic RNA in progeny virions [15] . Detection of negativestrand enteroviral RNA or the structural protein VP1 is an indication of transcription or translation of viral genomic RNA, respectively [16] . Enteroviruses have been isolated occasionally from patients with rheumatic heart disease [17] and enterovirus infection is associated with rheumatic fever or rheumatic heart disease by retrospective serology [18] . Enteroviral antigens were detected in situ by immunofluorescence in autopsy samples of valve tissue or myocardium from valvulitis or acute rheumatic heart disease [19] [20] [21] and enteroviral RNA was found by reverse transcription-polymerase chain reaction in valvular samples from chronic rheumatic heart disease cases [22] . Changes in heart valves of mice or monkeys following experimental enterovirus infection closely resemble human (chronic rheumatic heart disease and viral antigens or particles were found in these pathological valves [23] [24] [25] ). However, evidence of viral replication or virus persistence in human valve tissue was lacking and an enteroviral aetiology of rheumatic heart disease needs further investigation. This study demonstrates a possible role of enterovirus infection in the pathogenesis of chronic rheumatic heart disease by detection of both the genomic and template strands of viral RNA and of the capsid protein VP1 in valvular tissue.
Methods

Patients and tissue samples
Valvular tissue samples from a total of 53 patients who underwent surgical valve replacement in Zhongshan Hospital, Shanghai Medical University between January 1999 and July 2000 were collected randomly. Of these, 33 patients (age 22-67 years, mean=44·3 years) had histopathologically proven, chronic rheumatic valvular disease (Table 1 ) and 20 (age 15-76 years, mean=51·7 years) suffered from other valvular diseases, i.e. Marfan's syndrome (3 cases) and degenerative valvular disease such as calcification or mucoid degeneration (17 cases; Table 2 ). Chronic rheumatic valvular disease was diagnosed by the Jones Criteria, including a history of typical or recurrent rheumatic fever with cardiac insufficiency, echocardiographic and electrocardiographic changes [26] and was confirmed by histopathology [27] . To preserve antigenicity, tissue samples were not decalcified during processing for immunohistochemistry. Myocardial tissue from a case of enteroviral myocarditis was used as a positive control [28] and tissue from an unused donor heart as a negative control.
Histology and immunohistochemistry
Serial 5 m sections were cut from formalin-fixed, paraffin-embedded valvular tissue. A monoclonal antibody (MAb: 5-D8/1; IgG2a), specific for an enterovirus group-common, non-conformational epitope on viral capsid protein VP1, normal mouse IgG2A and the detection system EnVision /HRP, were purchased from DAKO Ltd. (Cambridge U.K.). MAb clone 1A4, directed against the smooth muscle isoform of actin, was obtained from NeoMarkers (Fremont, U.S.A.). Immunohistochemistry for the enterovirus capsid protein VP1 was performed according to our published protocols [28, 29] .
Strand-specific in situ hybridization to enterovirus RNA
To detect genomic (positive strand) or template (negative strand) viral RNA, strand-specific oligonucleotide probes (Table 3) complementary to conserved, groupcommon sequences in the 5 non-translated region (5 NTR) of enterovirus RNA were 3 end-labelled with digoxigenin. The specificity of these probes has been established in previous studies [30, 31] . Mixtures of strandspecific probes were used to enhance sensitivity [32] . Hybridization and detection of hybrids were according to manufacturer's instructions (DIG oligonucleotide tailing kit; Roche Diagnostics Ltd, East Sussex, U.K.). For detection of negative-stranded viral RNA, nucleic acids were denatured by heating tissue sections at 65 for 15 min in 95% formamide/0·1 SSC, followed by quenching at 4 C for 5 min in 0·1 SSC before hybridization. Specificity of oligo-RNA hybridization was confirmed by pre-treatment of sections with DNase-free RNase at 37 C for 60 min and by use of a mixture of labelled and non-labelled enterovirus probes (1:10) or an irrelevant oligonucleotide probe specific for the 16S rRNA gene of Borrelia burgdorferi.
Results
Presence of specific strands of enterovirus RNA in valvular tissue from patients with chronic rheumatic valvular disease
Positive strand (genomic) virus RNA was detected by strand-specific in situ hybridization in tissue from 8 (24·2%) of 33 chronic rheumatic valvular disease cases; negative strand (template) virus RNA was also detected in 7 of these 8 patients, suggesting virus RNA replication ( Fig. 1; A , B, D, and E). Signals were localized in foci of scattered or clustered fibroblasts in valvular tissue. Although it was not possible to accurately quantify specific strands due to, for example, section variations, there appeared to be a reduced ratio of positive to negative strand viral RNA. In acute productive infection such a ratio is generally about 100 to 1. A reduced ratio of genomic and template strand RNA indicates aberrant viral transcription, a sign of persistent infection [33] [34] [35] . Specificity was confirmed by the absence of signal when hybridized without enterovirus probe or with probe specific for Borrelia burgdorferi ( Fig. 1; C, F) . Signal with a mixture of labelled and non-labelled (1:10) enterovirus probes was weaker. Hybridization signal was not abolished following pre-treatment of sections with RNase, but was less intense, showing a degree of RNase resistance (data not shown). All 20 cases in the comparison group were negative for either strand of enteroviral RNA.
Presence of enterovirus antigen in valvular tissue from patients with chronic rheumatic valvular disease
Sixteen (48·5%) of 33 chronic rheumatic heart disease cases were positive by immunohistochemistry for the enteroviral capsid protein VP1. The signal was localized in the cytoplasm of fibroblasts, scattered or in foci ( Fig.  1; G, I ) and in cells within thick-walled vessels including putative smooth muscle cells ( Fig. 1; J) . VP1 was found both in valvular tissue and adjacent myocardium in 3 of 4 cases ( Fig. 1; L) . Substitution of primary antibody with diluent or concentration-matched normal mouse IgG2a gave no signal on consecutive sections ( Fig. 1 ; H, K). All samples from patients in the comparison group were VP1 negative and myocardial tissue from enterovirus myocarditis (positive control) or unused donor heart (negative control) was positive and negative, respectively, as expected. All cases positive for enterovirus RNA were positive for viral capsid protein VP1 also (Table 1) . 
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MAb 1A4, specific for the smooth muscle isoform of actin, recognized smooth muscle cells in blood vessels in all samples, either myocardium or valve tissue from normal or diseased heart (data not shown). In contrast, the enterovirus-specific MAb 5-D8/1 did not cross-react non-specifically with blood vessels but reacted with VP1 localized in some smooth muscle cells within thick-walled vessels of tissue from chronic rheumatic valvular disease cases only. Enterovirus (Coxsackie B) replication in cultured animal aortic smooth muscle cells has been shown previously [36] . 
Discussion
Previous studies provided evidence of an aetiological role of enterovirus infection in acquired valvular heart disease or in rheumatic heart disease [18] [19] [20] [21] [22] 37, 38] . Clinically, some patients with heart disease due to enterovirus infection had pansystolic and persistent murmurs, suggesting the development of valve lesions during the course of the viral illness [39] . Follow-up studies in mouse showed that chronic valvular disease can result from a single episode of acute enterovirus infection [40] supporting the observation in man. These findings suggest that enterovirus infection may be involved in the progression of acute rheumatic heart disease to chronic valvular disease, an analogy with enteroviral myocarditis and progression to dilated cardiomyopathy.
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A high incidence of enterovirus involvement in chronic rheumatic heart disease was found in the present study. About one quarter of these patients were positive for both genomic and template strand virus RNA, detected by in situ hybridization (except one case: genomic strand only). In an earlier independent study [22] , surgical valvular tissue samples from 24 (38·1%) of 63 patients with chronic rheumatic heart disease were positive for enteroviral genomic RNA using reverse transcription polymerase chain reaction which is more sensitive than hybridization. At the virus protein level, VP1 was detected in nearly a half of the present chronic rheumatic heart disease cases (16 of 33, 48·5%), greater than the rate of viral RNA detection and greater than the detection of virus antigens reported previously [19, 21, 36] . This accords with our earlier observations in enteroviral myocardial disease [28] and is attributed to an improved immunostaining technique employing heat-mediated antigen retrieval, enterovirus group-specific MAb 5-D8/1 and the EnVision detection system. The conserved, non-conformational epitope detected by 5-D8/1 is well preserved in fixed tissue and is heat-stable. In contrast, enterovirus RNA is lost to a variable extent during fixation or histological processing, which may explain the difference in positivity between detection of capsid protein VP1 and virus RNA.
Concurrent detection of both genomic and template strand viral RNA as well as viral structural protein VP1 in situ is evidence of virus replication in the affected tissue. In productive replication of enteroviruses in cell culture or during acute infection, the positive strand RNA is synthesized in excess of about 100-fold over the negative strand RNA. Near equal abundance of positive and negative strands of viral RNA has been found in persistent enterovirus infection in man and experimental animals and is a marker of defective virus replication [16, [33] [34] [35] . Hybridization to negative strand RNA was not diminished by pre-treatment of tissue sections with RNase, suggesting that some was annealed with positive strands and that persistence of enteroviral RNA in tissue from chronic rheumatic heart disease involves the formation of double-stranded complexes. A recent study confirms that Coxsackievirus RNA persists in this form in mouse muscle [41] although a proportion of enterovirus RNA is present as an intermediate doublestranded replication in cytolytic, productive infection of cells in culture.
Animal studies showed that viral valvulitis results from invasion from adjacent myocardium [40] . In the present study, VP1 was found in valve tissue and adjacent myocardium in 3 of 4 chronic rheumatic valvular disease cases where both were available, supporting the concept of cell-to-cell spread of enterovirus in the course of cardiac infection. Consequently, cardiac insufficiency in chronic rheumatic heart disease may be due to both myocardial and valvular damage.
The pathogenesis of valve injury in rheumatic heart disease remains poorly understood. Localization of enterovirus VP1 in valvular tissue including thick-walled vasculature indicates that infection may have a direct role, as in enterovirus-infected myocytes or myocardial fibroblasts [42, 43] . An immune mechanism is possible, as infection with Group A streptococci or enteroviruses can induce autoantibodies recognizing cardiac myosin as a major antigen [44] . Epitopes shared between some enteroviruses and the streptococcal M protein and co-infection with these agents [45] make it difficult to distinguish between a viral or bacterial origin of autoantibodies in rheumatic heart disease. In any case, antiheart antibodies induced by exposure of previously cryptic self antigens by direct cardiac damage and bystander T-cell activation following enterovirus infection is an established alternative to molecular mimicry [46] . In conclusion, this study is the first demonstration of enterovirus replication in valvular tissue from chronic rheumatic heart disease and provides new evidence to support an aetiological role of these viruses in some case.
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